Skip to content

BEAURAING MEDICAL: what changed

BE 0479.984.110NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€184,131
2024 · €185,085-€954
Equity
€887,457
2024 · €703,326+€184,131
Cash
€112,030
2024 · €226,660-€114,630
Balance sheet total
€977,534
2024 · €818,753+€158,781

Largest movements

2024 to 2025
Assets
  • Current investments +€280,614

    up €280,614 (+50.4%), from €557,140 to €837,755

  • Cash -€114,630

    down €114,630 (-50.6%), from €226,660 to €112,030

    mainly Current investments (-€280,614) and Tax, wage and social debts (-€27,544)

Equity and liabilities
  • Reserves +€184,131

    up €184,131 (+26.6%), from €690,926 to €875,057

  • Tax, wage and social debts -€27,544

    down €27,544 (-29.5%), from €93,261 to €65,717

    of which Taxes: -€27,905

Income statement
  • Gross operating margin -€17,984

    down €17,984 (-6.5%), from €277,556 to €259,573

  • Financial income +€14,708

    up €14,708 (+182%), from €8,066 to €22,774

    of which Financial income: +€17,708

  • Depreciation -€7,545

    down €7,545 (-48.8%), from €15,475 to €7,929

  • Taxes +€5,577

    up €5,577 (+6.8%), from €82,067 to €87,644

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €185,085
Gross operating margin -€17,984
Staff costs +€346
Depreciation +€7,545
Other operating charges -€151
Financial income +€14,708
Financial charges +€158
Taxes -€5,577
Result 2025 €184,131
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€165,985
Investment -€280,614
Financing €0
Cash 2024 €226,660
Net result for the year +€184,131
Depreciation +€7,929
Smaller working-capital items -€994
Trade debts +€2,463
Tax, wage and social debts -€27,544
Current investments -€280,614
Cash 2025 €112,030
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €818,753 €977,534 +€158,781 +19.4%
Fixed assets 21/28 €32,666 €24,737 -€7,929 -24.3%
Tangible fixed assets 22/27 €24,096 €16,167 -€7,929 -32.9%
Land and buildings 22 €858 €429 -€429 -50.0%
Furniture and vehicles 24 €23,238 €15,738 -€7,500 -32.3%
Financial fixed assets 28 €8,570 €8,570 = 0.0%
Current assets 29/58 €786,087 €952,798 +€166,710 +21.2%
Amounts receivable within one year 40/41 - €599 +€599
Trade receivables 40 - €599 +€599
Current investments 50/53 €557,140 €837,755 +€280,614 +50.4%
Cash at bank and in hand 54/58 €226,660 €112,030 -€114,630 -50.6%
Deferred charges and accrued income 490/1 €2,287 €2,413 +€126 +5.5%
Total equity and liabilities 10/49 €818,753 €977,534 +€158,781 +19.4%
Equity 10/15 €703,326 €887,457 +€184,131 +26.2%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €690,926 €875,057 +€184,131 +26.6%
Distributable reserves 133 €690,926 €875,057 +€184,131 +26.6%
Amounts payable 17/49 €115,427 €90,077 -€25,350 -22.0%
Amounts payable within one year 42/48 €115,427 €90,077 -€25,350 -22.0%
Trade debts 44 €2,466 €4,929 +€2,463 +99.9%
Suppliers 440/4 €2,466 €4,929 +€2,463 +99.9%
Taxes, remuneration and social security 45 €93,261 €65,717 -€27,544 -29.5%
Taxes 450/3 €92,916 €65,011 -€27,905 -30.0%
Remuneration and social security 454/9 €345 €706 +€361 +105%
Other amounts payable 47/48 €19,701 €19,432 -€269 -1.4%
Remuneration, social security and pensions 62 €1,361 €1,015 -€346 -25.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,475 €7,929 -€7,545 -48.8%
Other operating charges 640/8 €1,271 €1,421 +€151 +11.8%
Gross operating margin 9900 €277,556 €259,573 -€17,984 -6.5%
Operating profit (loss) 9901 €259,450 €249,207 -€10,243 -3.9%
Financial income 75/76B €8,066 €22,774 +€14,708 +182%
Recurring financial income 75 €5,066 €22,774 +€17,708 +350%
Non-recurring financial income 76B €3,000 - -€3,000
Financial charges 65/66B €364 €206 -€158 -43.3%
Recurring financial charges 65 €364 €206 -€157 -43.3%
Non-recurring financial charges 66B €0 - -€0
Profit (loss) for the period before taxes 9903 €267,152 €271,775 +€4,623 +1.7%
Income taxes 67/77 €82,067 €87,644 +€5,577 +6.8%
Profit (loss) for the period 9904 €185,085 €184,131 -€954 -0.5%
Profit (loss) for the period to be appropriated 9905 €185,085 €184,131 -€954 -0.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.1m to €1.3m

Midpoint €1.2m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €887,457
Capitalised earnings €1.3m to €1.8m
Indication €1.1m to €1.3m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€887,457
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€887,457

Capitalised earnings

net result for the year (9904)
2025
€184,131
2024
€185,085
excluding non-recurring income and charges
€182,086
2023
€164,853
2022
-€7,809
2021
€79,130
Average result, excluding non-recurring income and charges
€177,023
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.3m / €1.5m / €1.8m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.